Mangoceuticals, Inc. focuses to develop, market, and sell various men's wellness products and services through a telemedicine platform. The company is headquartered in Dallas, Texas.
| Revenue (TTM) | 456,020 |
| Gross Profit (TTM) | 250,390 |
| EBITDA | $-15.87M |
| Operating Margin | -1576.00% |
| Return on Equity | -141.70% |
| Return on Assets | -69.90% |
| Revenue/Share (TTM) | $0.04 |
| Book Value | $0.96 |
| Price-to-Book | 0.59 |
| Price-to-Sales (TTM) | 16.98 |
| EV/Revenue | 19.37 |
| EV/EBITDA | -0.51 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -10.30% |
| Shares Outstanding | $17.17M |
| Float | $13.23M |
| % Insiders | 10.04% |
| % Institutions | 4.81% |